1. Home
  2. DBVT vs BLDE Comparison

DBVT vs BLDE Comparison

Compare DBVT & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DBVT
  • BLDE
  • Stock Information
  • Founded
  • DBVT 2002
  • BLDE 2014
  • Country
  • DBVT France
  • BLDE United States
  • Employees
  • DBVT N/A
  • BLDE N/A
  • Industry
  • DBVT Biotechnology: Biological Products (No Diagnostic Substances)
  • BLDE Aerospace
  • Sector
  • DBVT Health Care
  • BLDE Consumer Discretionary
  • Exchange
  • DBVT Nasdaq
  • BLDE Nasdaq
  • Market Cap
  • DBVT 239.9M
  • BLDE 215.1M
  • IPO Year
  • DBVT N/A
  • BLDE N/A
  • Fundamental
  • Price
  • DBVT $8.35
  • BLDE $3.49
  • Analyst Decision
  • DBVT Buy
  • BLDE Strong Buy
  • Analyst Count
  • DBVT 4
  • BLDE 2
  • Target Price
  • DBVT $14.81
  • BLDE $6.25
  • AVG Volume (30 Days)
  • DBVT 102.2K
  • BLDE 641.9K
  • Earning Date
  • DBVT 07-29-2025
  • BLDE 05-12-2025
  • Dividend Yield
  • DBVT N/A
  • BLDE N/A
  • EPS Growth
  • DBVT N/A
  • BLDE N/A
  • EPS
  • DBVT N/A
  • BLDE N/A
  • Revenue
  • DBVT $3,497,000.00
  • BLDE $251,485,000.00
  • Revenue This Year
  • DBVT $1,700.53
  • BLDE $5.58
  • Revenue Next Year
  • DBVT $535.67
  • BLDE $8.40
  • P/E Ratio
  • DBVT N/A
  • BLDE N/A
  • Revenue Growth
  • DBVT N/A
  • BLDE 8.67
  • 52 Week Low
  • DBVT $2.21
  • BLDE $2.35
  • 52 Week High
  • DBVT $12.78
  • BLDE $5.17
  • Technical
  • Relative Strength Index (RSI)
  • DBVT 42.98
  • BLDE 59.33
  • Support Level
  • DBVT $8.33
  • BLDE $3.39
  • Resistance Level
  • DBVT $9.92
  • BLDE $3.84
  • Average True Range (ATR)
  • DBVT 0.92
  • BLDE 0.18
  • MACD
  • DBVT -0.32
  • BLDE 0.02
  • Stochastic Oscillator
  • DBVT 4.53
  • BLDE 38.12

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

About BLDE Blade Air Mobility Inc.

Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.

Share on Social Networks: